Ciforadenant is a pharmaceutical raw material that functions as a potent, selective, oral A2A receptor antagonist. It is under investigation in clinical trials for attention deficit/hyperactivity disorder (ADHD).
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1202402-40-1
(+/-)-(cis)-dorzolamide hydrochloride
pharmaceutical raw material
Dorzolamide
pharmaceutical raw material
Cetrorelix
pharmaceutical raw material
Biapenem
pharmaceutical raw material
7-(5-methylfuran-2-yl)-3-[[6-[[(3S)-oxolan-3-yl]oxymethyl]-2-pyridinyl]methyl]triazolo[4,5-d]pyrimidin-5-amine
KURQKNMKCGYWRJ-HNNXBMFYSA-N
CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)CO[C@H]5CCOC5